Water intake, thirst, and copeptin responses to two dehydrating stimuli in lean men and men with obesity

Physiological systems responsible for water homeostasis and energy metabolism are interconnected. This study hypothesized altered responses to dehydration including thirst, ad libitum water intake, and copeptin in men with obesity.

[1]  Cory L. Butts,et al.  Osmotic stimulation of vasopressin acutely impairs glucose regulation: a counterbalanced, crossover trial. , 2019, The American journal of clinical nutrition.

[2]  M. Christ-Crain.  Vasopressin and Copeptin in health and disease , 2019, Reviews in Endocrine and Metabolic Disorders.

[3]  M. Myers,et al.  Leptin and the maintenance of elevated body weight , 2018, Nature Reviews Neuroscience.

[4]  W. K. Simmons,et al.  Interoceptive contributions to healthy eating and obesity. , 2017, Current opinion in psychology.

[5]  N. Morgenthaler,et al.  Vasopressin: physiology, assessment and osmosensation , 2017, Journal of internal medicine.

[6]  Christopher A. Zimmerman,et al.  Thirst , 2016, Current Biology.

[7]  C. Zuker,et al.  Thirst Driving and Suppressing Signals Encoded by Distinct Neural Populations in the Brain , 2014, Nature.

[8]  James Brian Byrd,et al.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension , 2014, Journal of Human Hypertension.

[9]  N. Kalupahana,et al.  The renin‐angiotensin system: a link between obesity, inflammation and insulin resistance , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[10]  N. Morgenthaler,et al.  Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  J. Stockand.  Vasopressin regulation of renal sodium excretion. , 2010, Kidney international.

[12]  E. Jéquier,et al.  Water as an essential nutrient: the physiological basis of hydration , 2010, European Journal of Clinical Nutrition.

[13]  A. Meinders,et al.  Physiologic hyperleptinemia in obesity does not affect vasopressin secretion in acute hypo- or hyperosmolality. , 2009, Clinical and investigative medicine. Medecine clinique et experimentale.

[14]  M. Cassell,et al.  Local production of angiotensin II in the subfornical organ causes elevated drinking. , 2007, The Journal of clinical investigation.

[15]  J. Struck,et al.  Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. , 2006, Clinical chemistry.

[16]  H. Vaudry,et al.  Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[18]  M. Fujishima,et al.  Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  B. O'dowd,et al.  Characterization of Apelin, the Ligand for the APJ Receptor , 2000, Journal of neurochemistry.

[20]  S. Eto,et al.  Centrally Administered Murine Leptin Stimulates Plasma Arginine-Vasopressin Secretion and Increases the Level of mRNA Expression in the Supraoptic Nucleus of Conscious Rats , 1999, Neuroendocrinology.

[21]  K. Maas,et al.  Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. , 1993, The Journal of pharmacology and experimental therapeutics.

[22]  E. Ravussin,et al.  Energy cost of physical activity on a metabolic ward in relationship to obesity. , 1991, The American journal of clinical nutrition.

[23]  P. Baylis,et al.  Reproducibility of osmotic and nonosmotic tests of vasopressin secretion in men. , 1991, The American journal of physiology.

[24]  P. Baylis,et al.  Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans. , 1991, The American journal of physiology.

[25]  H. Shimizu,et al.  Rat brain natriuretic peptide (BNP) reduces water intake following dehydration , 1990, Neuropeptides.

[26]  A. Caiazza,et al.  Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking. , 1990, Metabolism: clinical and experimental.

[27]  K. Nakao,et al.  Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats , 1988, Neuroscience Letters.

[28]  P. Chiodera,et al.  EFFECT OF OBESITY AND WEIGHT LOSS ON THE ARGININE VASOPRESSIN RESPONSE TO INSULIN‐INDUCED HYPOGLYCAEMIA , 1987, Clinical endocrinology.

[29]  K. Kangawa,et al.  α‐HUMAN ATRIAL NATRIURETIC POLYPEPTIDE REDUCES THE PLASMA ARGININE VASOPRESSIN CONCENTRATION IN HUMAN SUBJECTS , 1986, Clinical endocrinology.

[30]  M. Yasujima,et al.  Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. , 1986, The Journal of clinical endocrinology and metabolism.

[31]  M. E. Clark,et al.  Living with water stress: evolution of osmolyte systems. , 1982, Science.

[32]  J. Hershman,et al.  The role of vasopressin and prolactin in abnormal salt and water metabolism of obese patients before and after fasting and during refeeding. , 1977, Metabolism: clinical and experimental.